We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Adicet Bio Inc
5 own
15 watching
Current Price
$9.23
$0.1
(1.1%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
394.93M
52-Week High
21.87
52-Week Low
7.42
Average Volume
0.4M
Dividend Yield
0.04
P/E Ratio
21.7527
Market Capitalization394.93M52-Week High21.8752-Week Low7.42Average Volume0.4MDividend Yield0.04P/E Ratio21.7527What does the Adicet Bio Inc do?
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors or T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. Its products pipeline includes ADI-001, which is in Phase 1 clinical study to treat non-Hodgkin's lymphoma; and ADI-002 that is in Phase 1 clinical study for the treatment of hepatocellular carcinoma and other solid tumors. The company is based in Boston, Massachusetts.
Read More
How much money does Adicet Bio Inc make?
News & Events about Adicet Bio Inc.
Business Wire
2days ago
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on January 31, 2023. Six individuals hired by Adicet in January 2023 received, in the aggregate...
Ticker Report
14days ago
Shares of Adicet Bio, Inc. (NASDAQ:ACET Get Rating) have been assigned an average recommendation of Moderate Buy from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation and ...
Ticker Report
1month ago
Adicet Bio, Inc. (NASDAQ:ACET Get Rating) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 4,020,000 shares, an increase of 29.7% from the November 15th total of 3,100,000 shares. Approximately...
Business Wire
1month ago
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced positive safety and efficacy data from the Companys ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or...
Business Wire
2 months ago
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that the Company will host a webcast presentation on Sunday, December 11, 2022 at 9:00 a.m. EST to discuss the most recent data-cut...
Frequently Asked Questions
Frequently Asked Questions
What is Adicet Bio Inc share price today?
Can Indians buy Adicet Bio Inc shares?
How can I buy Adicet Bio Inc shares from India?
Can Fractional shares of Adicet Bio Inc be purchased?
What are the documents required to start investing in Adicet Bio Inc stocks?
What is today’s traded volume of Adicet Bio Inc?
What is today’s market capitalisation of Adicet Bio Inc?
What is the 52-Week High and Low Range of Adicet Bio Inc?
What percentage is Adicet Bio Inc down from its 52-Week High?
What percentage is Adicet Bio Inc up from its 52-Week Low?
Current Price
$9.23
$0.1
(1.1%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.